Craft

CanBas

Stock Price

¥928

2024-10-29

Market Capitalization

¥16.8 B

2024-10-29

CanBas Summary

Company Summary

Overview
CanBas (キャンバス) is a drug discovery company engaged in the research and development of anti-cancer agents. Its drug candidates include a calmodulin modulator and a small molecule reversible inhibitor designed for the treatment of solid tumors.
Type
Public
Status
Active
Founded
2000
Website
http://www.canbas.co.jp/
Cybersecurity rating
Sectors

Table of Contents

CanBas Financials

Summary Financials

Net income (H1, 2026)
(¥569.0M)
Cash (H1, 2026)
¥2.2B
EBIT (H1, 2026)
(¥600.3M)

Footer menu